These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 13779439)

  • 1. Chemotherapeutic activity of X-5079C in systemic mycoses of man.
    UTZ JP; ANDRIOLE VT; EMMONS CW
    Am Rev Respir Dis; 1961 Oct; 84():514-28. PubMed ID: 13779439
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapeutic studies on a new antifungal agent, X-5079C, effective against systemic mycoses.
    GRUNBERG E; BERGER J; TITSWORTH E
    Am Rev Respir Dis; 1961 Oct; 84():504-6. PubMed ID: 13709238
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapeutic and toxic activity of the antifungal agent X-5079C in experimental mycoses.
    EMMONS CW
    Am Rev Respir Dis; 1961 Oct; 84():507-13. PubMed ID: 13696713
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antifungal antibiotherapy].
    TOURAINE R; REY M
    Prog Med (Paris); 1962 Mar; 90():179-91. PubMed ID: 13922146
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic value of chlorofungin (8-oxyquinoline hydrochlorate).
    LONGHIN S; TEODOSIU T; BIBESCU I; BART J
    Rum Med Rev; 1959; 3():44-6. PubMed ID: 14418144
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined therapy of experimental coccidioidomycosis with X-5079C and amphotericin B.
    EMMONS CW; PIGGOTT WR
    Antibiot Chemother (Northfield); 1962 Jun; 12():371-6. PubMed ID: 13890142
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of deep mycotic infections with amphotericin B1 with particular emphasis on drug toxicity.
    BEARD HW; RICHERT JH; TAYLOR RR
    Am Rev Respir Dis; 1960 Jan; 81():43-51. PubMed ID: 13797902
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of the treatment of mycoses by new fungicide drugs].
    RDZANEK I
    Przegl Dermatol; 1960; 47():11-20. PubMed ID: 14436691
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of systemic mycoses with orally administered pimaricin: preliminary report.
    NEWCOMER VD; STERNBERG TH; WRIGHT ET; REISNER RM; McNALL EG; SORENSEN LJ
    Ann N Y Acad Sci; 1960 Aug; 89():240-6. PubMed ID: 13728644
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of amphotericin B in man.
    ANDRIOLE VT; KRAVETZ HM
    JAMA; 1962 Apr; 180():269-72. PubMed ID: 13861516
    [No Abstract]   [Full Text] [Related]  

  • 11. Amphotericin B and its use in the deep mycoses.
    FIELD LM
    Mo Med; 1960 Sep; 57():1135-8. PubMed ID: 13822684
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of the treatment of 74 cases of tropical mycoses with cuprammonium laurylsulfonate].
    NGUYEN VINH NIEN
    Bull Soc Pathol Exot Filiales; 1960; 53():476-93. PubMed ID: 13728731
    [No Abstract]   [Full Text] [Related]  

  • 13. Experience with amphotericin B for the treatment of systemic mycoses.
    SEABURY JH; DASCOMB HE
    AMA Arch Intern Med; 1958 Dec; 102(6):960-76. PubMed ID: 13593903
    [No Abstract]   [Full Text] [Related]  

  • 14. The action of sulfonamides on certain fungi pathogenic to man.
    WOLF FT
    Mycologia; 1946; 38():213-9. PubMed ID: 21020672
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of amphotericin treatment failures in systemic fungal disease.
    UTZ JP; ANDRIOLE VT
    Ann N Y Acad Sci; 1960 Aug; 89():277-82. PubMed ID: 13779440
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of refractory fungus infections with fungacetin (triacetin).
    KARNS ME; PARKER R
    J Am Podiatry Assoc; 1959 Sep; 49():411-2. PubMed ID: 14404545
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of the use of a 4 percent epilin plaster in patients with mycoses of the scalp].
    L'VOV LA; PORIADINA RN
    Vestn Rentgenol Radiol; 1960 Aug; 34():26-7. PubMed ID: 13757905
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered sulfobromophthalein metabolism in man induced by the antifungal agent X-5079C.
    ANDRIOLE VT; UTZ JP; SABESIN SM
    Am Rev Respir Dis; 1961 Oct; 84():538-48. PubMed ID: 13683502
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combined surgical and Fungifen therapy of onychomycosis, leukonychia, mycoses of recesses and mycotic paronychia].
    FONYO J
    Orv Hetil; 1962 Jun; 103():1135-7. PubMed ID: 13893975
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with amphotericin B.
    SEABURY JH; DASCOMB HE
    Ann N Y Acad Sci; 1960 Aug; 89():202-20. PubMed ID: 13749466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.